Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-31,640
Closed -$7.86M – 566
2017
Q1
$7.86M Buy
31,640
+159
+0.5% +$38.3K 0.03% 338
2016
Q4
$7.07M Sell
31,481
-240,356
-88% -$52.2M 0.02% 346
2016
Q3
$61M Sell
271,837
-17,224
-6% -$3.88M 0.22% 95
2016
Q2
$68M Sell
289,061
-154
-0.1% -$33.4K 0.25% 97
2016
Q1
$58.6M Sell
289,215
-156,853
-35% -$29.6M 0.22% 103
2015
Q4
$84.5M Sell
446,068
-527,596
-54% -$98.8M 0.32% 86
2015
Q3
$181M Buy
973,664
+8,838
+0.9% +$1.67M 0.74% 30
2015
Q2
$165M Buy
964,826
+477
+0% +$81.5K 0.6% 43
2015
Q1
$161M Buy
964,349
+2,368
+0.2% +$406K 0.58% 47
2014
Q4
$160M Sell
961,981
-743
-0.1% -$120K 0.58% 52
2014
Q3
$137M Buy
962,724
+393
+0% +$58K 0.52% 58
2014
Q2
$138M Sell
962,331
-6,432
-0.7% -$919K 0.53% 58
2014
Q1
$143M Sell
968,763
-21,310
-2% -$2.95M 0.55% 57
2013
Q4
$133M Buy
990,073
+936
+0.1% +$123K 0.51% 62
2013
Q3
$114M Sell
989,137
-13,999
-1% -$1.61M 0.46% 65
2013
Q2
$109M Hold
1,003,136
– – 0.45% 60

Other funds holding BCR

Amundi's BCR Position: Q2 2017 in Review

Amundi sold out of CR Bard (BCR) in Q2 2017, closing a stake of 31,640 shares — an estimated $7.86M sold.

Amundi first reported a position in BCR in Q2 2013 and held it in 16 quarters. The position peaked at $181M in Q3 2015. 675 funds tracked by Wall St. Rank hold BCR as of Q2 2017.

  • Amundi reported no remaining CR Bard position as of Q2 2017 after selling out during the quarter.
  • Amundi sold 31,640 CR Bard shares in Q2 2017, an estimated $7.86M.
  • Amundi first reported a position in CR Bard in Q2 2013 and held it in 16 quarters.
  • Amundi's CR Bard position peaked at $181M in Q3 2015.
  • 675 funds tracked by Wall St. Rank held CR Bard as of Q2 2017.

Based on Amundi's 13F filing for Q2 2017, filed 1 Aug 2017.